Jan 24 (Reuters) - Allscripts Healthcare Solutions Inc
MDRX.O :
* SEES Q4 REVENUE $390 MILLION TO $395 MILLION
* APPROVED A NEW SHARE REPURCHASE PROGRAM UP TO $250 MILLION
* NEW SHARE REPURCHASE PROGRAM DOES NOT HAVE A TERMINATION
DATE
* NEW SHARE REPURCHASE PROGRAM REPLACES PREVIOUS
AUTHORIZATION TO
REPURCHASE UP TO $350 MILLION OF COMMON STOCK
* Q4 REVENUE VIEW $386.8 MILLION -- REFINITIV IBES DATA
* EXPECTS FY ADJUSTED EBITDA TO BE BETWEEN $295 MILLION AND
$300
MILLION, AN INCREASE FROM PRIOR OUTLOOK RANGE
Source text for Eikon: ID:nBw5xYz5Qa
Further company coverage: MDRX.O
((Reuters.Briefs@thomsonreuters.com;))